- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Healthcare Businesswomen's Association recognizes Delix Therapeutics and Pfizer UK
The companies have shown a commitment to enhancing greater equity for women.
To showcase the impactful commitment and outcomes of equitable practices for women in the workplace, the Healthcare Businesswomen’s Association (HBA) recognizes Delix Therapeutics and Pfizer UK Ltd., for initiatives working to close the gender gap in the healthcare and life science industries. The awards will be presented on Thursday, November 3, in conjunction with HBA’s Annual Conference in Philadelphia.
HBA’s Advancement. Commitment. Engagement. (ACE) Awards recognize companies committed to ensuring that gender diversity and leadership opportunities for women are part of their organizational DNA. An independent panel of healthcare industry leaders selects ACE Award recipients for their excellence in advancing their female talent and removing the systemic barriers preventing timely progress to parity. Award criteria include measurable results, business performance, stewardship, execution, and sustainability.
Read more here.
Fierce Females in the Life Science Space
March 29th 2024In this week’s episode, in recognition of international women’s month, Editor Miranda Schmalfuhs has compiled audio clips from interviews with female KOLs that she's been fortunate enough to speak with over this past month for content across a few of our brands.
